Niagen Bioscience announced the launch of Niagen Skincare Innovation Lab and its inaugural release, Niagen NanoCloud, a dermatologist-tested topical skincare product powered by Niagen Bioscience’s flagship, patented nicotinamide riboside ingredient. “Niagen Skincare Innovation Lab is a strategic step into exploring how Niagen can extend into new consumer categories,” said Rob Fried, Chief Executive Officer of Niagen Bioscience. “With Niagen NanoCloud, we are introducing our first topical prototype in a format designed to protect potency, generate consumer insight, and help inform future product development.”
The limited-release Niagen NanoCloud was developed to address a key challenge in NAD+ skincare: water-based NAD+ and precursor products can degrade well before they reach the skin, because the molecules are unstable in water. Thanks to waterless, sealed sachets, Niagen NanoCloud keeps Niagen intact until the moment of use.
What Makes This Trend Stand Out
- Waterless Formulations
- Offers longer shelf life and higher potency for hydration-sensitive actives, shifting preservation and formulation paradigms.
- Single-use Sachet Delivery
- Provides precise-dose, aseptic delivery that reduces degradation and supports on-the-go sampling and limited-release strategies.
- Ingredient Stability-first Design
- Prioritizes molecular integrity over traditional emulsion aesthetics, prompting development of novel stabilization technologies and carrier systems.
Sectors Adopting This
- Skincare-cosmetics
- Sees growth in premium travel-friendly, high-potency serums packaged in waterless sachets as a means of product differentiation.
- Pharmaceutical-topicals
- Benefits from stability-focused packaging that enables more reliable topical delivery of labile actives and expands outpatient formulation options.
- Packaging-materials
- Faces rising demand for hermetic, biodegradable sachets and micro-dosing dispensers that maintain sterility without conventional preservatives.
